Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xiakucao oral liquid for Hashimoto's thyroiditis
ChiCTR1900027884Phase 4Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Oct 2018
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of prunella vulgaris extract in Hashimoto's disease (2 arms), sponsored by First Hospital of China Medical University. Primary endpoints: Thyroid peroxidase antibody, Antithyroglobulin antibody and 2 more. Started Oct 2018; status: recruiting.
02
Drugs
prunella vulgaris extract
03
Conditions
Hashimoto's disease
Beyond the preview
Go deeper on ChiCTR1900027884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900027884.